CN102274472A - 一种治疗女性痛经的中药贴剂及制备 - Google Patents
一种治疗女性痛经的中药贴剂及制备 Download PDFInfo
- Publication number
- CN102274472A CN102274472A CN2011101946996A CN201110194699A CN102274472A CN 102274472 A CN102274472 A CN 102274472A CN 2011101946996 A CN2011101946996 A CN 2011101946996A CN 201110194699 A CN201110194699 A CN 201110194699A CN 102274472 A CN102274472 A CN 102274472A
- Authority
- CN
- China
- Prior art keywords
- medicine
- rhizoma
- treatment
- chinese
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 206010013935 Dysmenorrhoea Diseases 0.000 title abstract description 36
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 230000027758 ovulation cycle Effects 0.000 claims abstract description 6
- 230000003821 menstrual periods Effects 0.000 claims abstract description 5
- 239000002674 ointment Substances 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 235000017803 cinnamon Nutrition 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims abstract 2
- 210000000582 semen Anatomy 0.000 claims description 17
- 238000011084 recovery Methods 0.000 claims description 3
- 239000002390 adhesive tape Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 2
- 210000001113 umbilicus Anatomy 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 241000723347 Cinnamomum Species 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 37
- 210000004369 blood Anatomy 0.000 abstract description 37
- 208000002193 Pain Diseases 0.000 abstract description 31
- 230000036407 pain Effects 0.000 abstract description 31
- 238000010792 warming Methods 0.000 abstract description 16
- 210000000952 spleen Anatomy 0.000 abstract description 15
- 210000003734 kidney Anatomy 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 230000001225 therapeutic effect Effects 0.000 abstract description 7
- 230000004069 differentiation Effects 0.000 abstract description 4
- 239000007924 injection Substances 0.000 abstract description 4
- 238000002347 injection Methods 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000008859 change Effects 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 235000016854 Cyperus rotundus Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 240000007049 Juglans regia Species 0.000 abstract 1
- 235000009496 Juglans regia Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 206010041956 Stasis syndrome Diseases 0.000 abstract 1
- 241000301400 Trogopterus Species 0.000 abstract 1
- 240000001398 Typha domingensis Species 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 208000005634 blind loop syndrome Diseases 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 23
- 230000000694 effects Effects 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- 238000012360 testing method Methods 0.000 description 11
- 206010000087 Abdominal pain upper Diseases 0.000 description 9
- 201000000736 Amenorrhea Diseases 0.000 description 9
- 206010001928 Amenorrhoea Diseases 0.000 description 9
- 231100000540 amenorrhea Toxicity 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 231100000915 pathological change Toxicity 0.000 description 5
- 230000036285 pathological change Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 210000004392 genitalia Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 239000008964 yuanhu zhitong Substances 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 201000009273 Endometriosis Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010021033 Hypomenorrhoea Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000002105 tongue Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241001671653 Aconitum carmichaelii Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033847 Parametritis Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000007893 Salpingitis Diseases 0.000 description 1
- 206010059516 Skin toxicity Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010063146 Uterine hypoplasia Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229950002007 estradiol benzoate Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 208000005963 oophoritis Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 208000025421 tumor of uterus Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种治疗女性痛经的中药贴剂及制备,具体地说是肉桂、炮姜、当归、川芎、赤芍、桃仁、香附子、五灵脂、生蒲黄、胡桃仁和琥珀11种中药按一定分量配比研成粉末,经期治疗时取1~3g药末,浸于60°白酒中,和匀,调成膏状,分别将药膏填敷于肚脐内,外用透气胶布固定,24小时换药一次,连敷5~6天,连续3个月经周期为一疗程,一般1~2个疗程痊愈,不再复发。本发明结合穴位辨证理论,调理兼施,温补脾肾、命门,清热利湿、活血化瘀,适用于寒湿、瘀引发的妇女痛经,疗效确切,治愈率高,且操作方便,不吃药、不打针、不输液,无任何不适及伤痛,深受患者所接受。
Description
技术领域
本发明涉及一种治疗女性痛经的中药贴剂及制备,属于中药领域。
背景技术
痛经(Dysmenorrhea)是指妇女正值经期或行经前后出现周期性小腹疼痛,或痛引腰骶,甚则剧痛昏厥者,是妇科临床中的常见病、多发病,严重影响工作和生活质量。中医认为,痛经病位在子宫、冲任,以“不通则痛”或“不荣则痛”为主要病机。治疗以调理气血为主,依据疼痛的时间、性质、部位、程度并结合月经期量、色、质兼症、舌、脉进行辨证分型论治。痛经又分为原发性和继发性两种,原发性痛经多为少女初潮后即开始出现,或与体质因素有关,或因经期饮冷受寒,寒客胞中,气失温运,瘀血内留,致胞脉受阻,不通而痛,占痛经的90%以上。继发性痛经多为育龄期妇女经期受寒,或产后不慎,当风受寒,寒湿客于胞中,或有多次人流史,胞脉受损,离经之血瘀滞胞宫、胞脉,瘀血阻滞,气机不畅,津液运行障碍,聚而生湿酿痰,湿、痰、瘀日久而成症瘕之病。
对于痛经诊疗,西医临床上通过B超、X线以对原发性痛经和继发性痛经作鉴别诊断,治疗以止痛、镇痛、解痉为主,若患输卵管炎,卵巢炎,子宫周围炎等,应用抗生素积极治疗。子宫发育不良者,可口服乙烯雌酚治疗,疼痛严重时,可口服去痛片、阿托品、消炎痛、复方阿司匹林及非那根等,雌孕激素临床应用可抑制子宫收缩或抑制排卵而止痛,但因其抑制卵巢正常功能,故应慎用。
中医治疗痛经方法繁多,临床常见的有针灸、推拿、按摩、磁疗、食疗等法,一些中成药也可以治疗痛经,如“元胡止痛片”“妇科十味片”。针灸、推拿等多以结合穴位辨证施治,虽然取得一定的效果,但因操作中取穴的精确、施针手法,按摩的力道、手法等都会影响治疗效果,所以不利于广泛应用。检索近年来有关治疗痛经的专利,仅公布的发明专利有近260项,其中以中药汤剂、胶囊及治疗仪器居多,外用敷治较少。鉴于此,发明人总结自己30余年临床工作经验,发明了一种调理兼施,温补脾肾,清热利湿、活血化瘀,适用于寒湿、瘀引发的妇女痛经的中药贴剂。
发明内容
本发明的目的就是针对上述临床中现有治疗存在的问题,而提供一种便捷有效的中医药贴剂。即从痛经的病理机制出发,选取任脉上的要穴——神阙穴,敷以药贴,能快速渗入体内,利于吸收,改善机体内寒、瘀状况,调和脾肾,使气血营和通畅。加之中药的有效成分又是纯天然的植物蛋白、动物蛋白和矿物质的微量元素,进入人体后,供机体选择其有效成分,并参与人体的新陈代谢,从整体上调理人体脏腑、气血的平衡,使免疫功能提高,肝、脾、肾的生理功能恢复正常,故能祛病固本。又因中草药对人体副作用较小,且能治本。为此,选择中医中药治疗痛经,是行之有效的选择。
本发明调理兼施,温补脾肾,清热利湿、活血化瘀,适用于寒湿、瘀引发的妇女痛经,疗效确切,治愈率高,且操作方便,不吃药,不打针,不输液,无任何不适及伤痛,深受患者所接受。
本发明选择肉桂、炮姜、当归、川芎、赤芍、桃仁、香附子、五灵脂、生蒲黄、胡桃仁和琥珀11种中药进行组合,依据中药相生相克的原则,将这些药物有效的组合使得各药物功效产生协同作用,从而达到清热利湿、调和气血的功效,促使脾肾营和有度。其中肉桂性大热,味辛、甘,归肾、脾、心、肝经,具有补火助阳,引火归源,散寒止痛,活血通经功能。用于阳痿、宫冷、心腹冷痛、虚寒吐泻、经闭、痛经、温经通脉。炮姜味苦、涩,性温、辛、热,归脾、胃、肾、心、肺经。温中散寒,温经止血。用于脾胃虚寒,腹痛吐泻,吐衄崩漏,阳虚失血。当归性温,味甘、辛,归肝、心、脾经。有补血活血、调经止痛、润肠通便之效。用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。川芎味辛性温,归肝、胆、心包经。用于胸胁疼痛、风湿痹痛、症瘕结块、疮疡肿痛、跌扑伤痛、月经不调、经闭痛经、产后瘀痛等病症。赤芍味苦性微寒,归肝经,清热凉血,散瘀止痛。用于温毒发斑、吐血衄血、目赤肿痛、肝郁胁痛、经闭痛经、症瘕腹痛、跌扑损伤、痈肿疮疡。桃仁味苦、甘,性平,归心、肝、大肠经,有活血祛瘀,润肠通便,止咳平喘。用于经闭、痛经、癥瘕痞块、跌扑损伤、肠燥便秘,桃仁有增加药物吸收作用。香附子性辛微苦甘、平,入肝、三焦经,理气解郁,调经止痛。用于肝郁气滞,胸、胁、脘腹胀痛,消化不良,月经不调,经闭痛经,寒疝腹痛,乳房胀痛。五灵脂性味甘温,无毒,入肝经,具有疏通血脉,散瘀止痛的功效,主治血滞、经闭、腹痛、胸胁刺痛、跌扑肿痛和蛇虫咬伤等症。生蒲黄性平味甘,归肝、心包经,有止血、化瘀、通淋之效,用于吐血、衄血、咯血、崩漏、外伤出血、经闭、痛经、脘腹刺痛、跌打肿痛、血淋湿痛。胡桃仁味甘性温,归肾、肺、大肠经。有补肾、温肺、润肠之效,用于腰膝酸软、阳痿遗精、虚寒喘嗽、大便秘结。琥珀味甘性平,归心、肝、小肠经、膀胱、肺、脾经,有镇静、利尿、活血之功效,用于惊风、癫痫、心悸、失眠、小便不利、尿痛、尿血、闭经等症。
本发明药物组分的用量也是经过发明人进行大量实验结果得出,下列各组用量范围都具有较好疗效:
本发明药物各组分用量是肉桂10~20g、炮姜8~22g、当归15~25g、川芎15~25g、赤芍10~20g、桃仁10~20g、香附子8~22g、五灵脂10~20g、生蒲黄10~20g、胡桃仁5~19g、琥珀3~7g。
优选为:肉桂15g、炮姜15g、当归20g、川芎20g、赤芍15g、桃仁15g、香附子15g、五灵脂15g、生蒲黄15g、胡桃仁12g、琥珀5g。
其制备方法如下:
(1)称取将上述11种药物,分别清洗去杂干燥后研成细末,混合备用;
(2)将混合后的药末过80~100目筛装瓶密封备用;
(3)经期治疗时取1~3g药末,浸于60°白酒中,和匀,调成膏状,分别将药膏填敷于肚脐内,外用透气胶布固定,24小时换药一次,连敷5~6天,连续3个月经周期为一疗程,一般1~2个疗程痊愈,不再复发。
本发明的特点:1.中医药标本兼治及辨证施治的的原则,结合中医穴位疗法,利于根除女性痛经之顽疾;
2.调理兼施,温补脾肾、命门,清热利湿、活血化瘀,适用于寒湿、瘀引发的妇女痛经;
3.疗效确切,治愈率高,且操作方便,不吃药、不打针、不输液,无任何不适及伤痛,深受患者所接受。
具体实施方式
以下通过实验例来进一步阐述本发明所述药物的有益效果,这些试验例包括本发明药物(以下称温经祛瘀贴)的药效学试验和临床疗效观察试验。
试验例1 本发明温经祛瘀贴毒性试验
(1)急性毒性试验:选取正常皮肤及人为破损皮肤SD大鼠各10只,分别贴敷5倍常人剂量温经祛瘀贴,多次贴敷,均未出现皮肤过敏及毒副反应。
(2)长期毒性试验:选取SD大鼠80只,体重60~80g,随机分成四组,每组20只,雌雄各半,单笼饲养。设2倍、5倍、10倍三个剂量组分别煎汤给受试动物灌胃,连续30天。试验期间各组动物均喂饲基础饲料,并自由进食、饮水。实验结束后处死大鼠,对肝、肾、脾等进行病理组织学检查(石蜡切片),试验结果如下表。
表1 各组动物脏体比值结果(%)
从表1可以看出,所有动物肝、肾、脾等均未见明显病理改变,说明温经祛瘀贴无毒副作用、安全可靠。
试验例2 对大鼠离体子宫平滑肌收缩的影响:
取未孕健康雌性Wistar大鼠50只,体重180~220g,分成五组。选取承德天原药业有限公司生产的元胡止痛片(主要成分延胡索、白芷)作为阳性对照组,于实验前每日腹腔注射苯甲酸雌二醇1mg/kg,连续2天。第三天处死大鼠,迅速剖腹,取出子宫,立即置于盛有洛氏液的玻璃皿中。取一侧子宫的中段2cm,轻柔剥离结缔组织和脂肪组织,一端固定于麦氏浴槽,浴槽内盛30mL洛氏液。另一端与肌肉张力换能器相连,下为恒温浴箱,温度控制在(37±10)℃。并不断向麦氏浴槽中通入O2,气泡控制在每秒1~2个。肌肉张力换能器输入带有应用软件Med lab生物信号采集处理系统的计算机。待标本稳定后,描记一段正常活动曲线,从麦氏浴槽上方依次加入各组药液。此实验中加入的受试药为中药(温经祛瘀贴)原液(不含透皮吸收促进剂和基质),浓度分别5mg/mL、25mg/mL、50mg/mL。阳性对照药元胡止痛片冲剂浓度为10mg/mL。观察记录子宫收缩力(最大值)和频率变化,并计算各指标的抑制率:抑制率%=(给药前指标-给药后指标)/给药前指标*100%。
实验表明,温经祛瘀贴(药液,下同)在5mg/mL浓度时,即能有效抑制正常离体大鼠子宫平滑肌自发收缩的频率和幅度;25mg/mL时,自发收缩几乎完全被抑制。结果见表2。
注:与给药前比较,1)t=-6.1443、-14.4599、-3.4641、-5.2985、-10.0459,P<0.01;
2)t’=-5.0377、-16.1475,P<0.01。
试验例3
一、一般资料
1.病人来源:本试验共观察病例150例,原发性、继发性各50例,对照组50例,其所有病例都来自临床。
二、纳入病例标准
以痛经为主症,符合中医辨证标准,经妇检无明显器质性病变。
1.中医辨证标准:
(1)寒湿凝滞证:经期小腹冷痛,得热则舒,经量少,色紫暗,有血块,伴有四肢冷,小便清长等症,是为寒湿凝滞证痛经;
(2)气滞血瘀型:症见每于经前一二天或月经期小腹胀痛,拒按,或伴胸胁乳房胀,或经量少,或经行不畅,经色紫黯有块,血块排出后痛减,经净疼痛消失,舌紫黯或有瘀点,脉弦或弦滑。
2.西医诊断标准
(1)原发性痛经:经妇科检查生殖器官无明显病变者,故又称功能性痛经,多见于青春期、未婚及已婚未育者;
(2)继发性痛经:经妇科检查生殖器官有明显病变者,如子宫内膜异位症、盆腔炎、肿瘤等症状引起的痛经。
3.病例排查
(1)继发性痛经,生殖器官有明显的器质性病变,经妇科检查、超显像、腹腔镜等技术检查有盆腔炎、子宫肿瘤、子宫内膜异位病变而致的痛经;
(2)合并心、脑、肾、肝、肺等重大器质性疾病者;
(3)合并传染病、恶性肿瘤以及精神病患者;
(4)同时应用其他方法治疗痛经者或对本药过敏者。
三、试验方法
采用单盲完全随机分组,原发性、继发性痛经观察组以中药组方温经祛瘀贴治疗,一日1次;对照组采用西医药物治疗。每月经周期用药5~6天,观察3个月经周期(一个疗程)变化。
四、疗效判定标准
参考1993年卫生部颁布的《中药新药治疗痛经的临床研究指导原则》所确定的疗效判定标准进行疗效判定。痊愈:治疗后,腹痛及其他症状消失,停药3个月经周期未复发者;显效:治疗后,腹痛明显减轻,其余症状好转,不服止痛药能坚持工作;有效:治疗后,腹痛疗效观察减轻,其余症状好转,服止痛药能坚持工作;无效,腹痛及其症状无改变者;复发,治疗后又有明显改善,但又重复出现腹痛。
2.两组综合疗效,见表3
表3两组综合疗效比较
从表3可以看出,经Ridit分析,两组间综合疗效有显著差异(p<0.01),观察组明显优于对照组。
六、结论
150例临床试验结果显示,此种温经祛瘀贴对治疗外邪犯、寒湿、瘀引发的妇女痛经具有显著疗效,其综合症状疗效总有效率分别为96%。综合对比该中药贴剂疗效确切,敷用方便,且在应用过程中未发现明显不良反应和毒副作用。
Claims (5)
1.一种治疗女性痛经的中药散剂及制备,其特征在于它主要是由以下重量份的原药研制而成:肉桂10~20g、炮姜8~22g、当归15~25g、川芎15~25g、赤芍10~20g、桃仁10~20g、香附子8~22g、五灵脂10~20g、生蒲黄10~20g、胡桃仁5~19g、琥珀3~7g。
2.根据权利要求1的药物,其中原料药的用量为:肉桂15g、炮姜15g、当归20g、川芎20g、赤芍15g、桃仁15g、香附子15g、五灵脂15g、生蒲黄15g、胡桃仁12g、琥珀5g。
3.权利要求1或2所述药剂的制备方法,它包括下列步骤:
a)称取各原料药肉桂、炮姜、当归、川芎、赤芍、桃仁、香附子、五灵脂、生蒲黄、胡桃仁、琥珀,分别清洗去杂干燥后备用;
b)将所述份量配比的中药肉桂、炮姜、当归、川芎、赤芍、桃仁、香附子、五灵脂、生蒲黄、胡桃仁和琥珀研成细末,混合备用。
4.根据权利要求3中所述药物,过80~100目筛,即得权利要求1中所述的中药方剂。
5.根据权利要求4所述的中药方剂,经期治疗时取1~3g药末,浸于60°白酒中,和匀,调成膏状,分别将药膏填于敷于肚脐内,外用透气胶布固定,24小时换药一次,连敷5~6天,连续3个月经周期为一疗程,一般1~2个疗程痊愈,不再复发。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101946996A CN102274472A (zh) | 2011-07-13 | 2011-07-13 | 一种治疗女性痛经的中药贴剂及制备 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101946996A CN102274472A (zh) | 2011-07-13 | 2011-07-13 | 一种治疗女性痛经的中药贴剂及制备 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102274472A true CN102274472A (zh) | 2011-12-14 |
Family
ID=45100414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101946996A Pending CN102274472A (zh) | 2011-07-13 | 2011-07-13 | 一种治疗女性痛经的中药贴剂及制备 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102274472A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102847109A (zh) * | 2012-08-28 | 2013-01-02 | 赵爱良 | 一种治疗痛经的脐贴膏及其制备方法 |
CN105534151A (zh) * | 2015-12-28 | 2016-05-04 | 吴华娟 | 一种治疗痛经中药座垫 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1650980A (zh) * | 2004-11-30 | 2005-08-10 | 许跃华 | 以当归等为配方的治疗妇科痛经药的制备方法 |
-
2011
- 2011-07-13 CN CN2011101946996A patent/CN102274472A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1650980A (zh) * | 2004-11-30 | 2005-08-10 | 许跃华 | 以当归等为配方的治疗妇科痛经药的制备方法 |
Non-Patent Citations (1)
Title |
---|
秦淑芳: "韩冰教授从任脉论治疾病的经验介绍", 《新中医》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102847109A (zh) * | 2012-08-28 | 2013-01-02 | 赵爱良 | 一种治疗痛经的脐贴膏及其制备方法 |
CN105534151A (zh) * | 2015-12-28 | 2016-05-04 | 吴华娟 | 一种治疗痛经中药座垫 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103816254B (zh) | 一种用于治疗风寒湿痹、筋骨劳损的中药熏蒸制剂 | |
CN103585378B (zh) | 一种治疗女性不孕症的中药组合物及其制备方法 | |
CN103550695B (zh) | 一种治疗乳腺癌的药物 | |
CN104784673B (zh) | 一种用于小儿腹泻的中药脐贴 | |
CN104983818A (zh) | 一种治疗妇科疾病的中药及其制备方法 | |
CN101698020B (zh) | 一种治疗股骨头坏死的中药制剂及其制备方法 | |
CN105412787A (zh) | 治疗产后月经不调的药物 | |
CN104474500A (zh) | 一种补血调经的中药保健品及其制备方法 | |
CN101961458A (zh) | 一种治疗股骨头坏死的内服药物 | |
CN100444886C (zh) | 一种治疗先兆性流产的中药 | |
CN104524071A (zh) | 一种治疗原发性肾病的药物组合物及其用途 | |
CN101804181B (zh) | 治疗前列腺炎的中药制剂及其制备方法 | |
CN106421666A (zh) | 一种治疗肝郁肾虚型卵巢早衰的药物组合物 | |
CN102847074A (zh) | 治疗强直性脊柱炎的瘀血痹通丸 | |
CN105250556A (zh) | 一种用于治疗多囊卵巢综合征的中药药物 | |
CN102274472A (zh) | 一种治疗女性痛经的中药贴剂及制备 | |
CN103735792B (zh) | 一种治疗月经不调的药物及其制备方法 | |
CN102218119B (zh) | 治疗风湿和股骨头坏死及月子病的中草药 | |
CN100571747C (zh) | 一种治疗痛经的中药汤剂 | |
CN105079549A (zh) | 一种治疗狼疮性肾炎的中药 | |
CN105169265A (zh) | 一种治疗偏瘫的中药组合物及其制备方法 | |
CN104398789A (zh) | 一种治疗缺铁性贫血的中药汤剂 | |
CN104189615B (zh) | 一种治疗崩漏的中药制剂及其制备方法 | |
CN104257813B (zh) | 一种调理气血的中药组合物及其制备方法 | |
CN103800561A (zh) | 一种治疗肾性血尿的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20111214 |